Oskar Steinbrecher
Overview
Explore the profile of Oskar Steinbrecher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinbrecher O, Kiesewetter B, Dolak W, Brand R, Simonitsch-Klupp I, Raderer M
Hematol Oncol
. 2024 Dec;
43(1):e70007.
PMID: 39624879
Extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma) is an indolent B-cell lymphoma with a distinct affinity for mucosal structures. Most commonly arising in the stomach,...
2.
Steinbrecher O, Brodowicz T, Popov P, Lamm W
In Vivo
. 2023 Dec;
38(1):385-389.
PMID: 38148100
Background/aim: Soft tissue sarcomas are rare and heterogenous malignancies with high recurrence rates following resection and a poor prognosis in advanced stages. Eribulin is used in metastatic soft tissue sarcoma...
3.
Steinbrecher O, Brodowicz T, Raderer M, Scharrer A, Fabsits J, Lamm W
Oncology
. 2022 Oct;
101(2):89-95.
PMID: 36273457
Introduction: Soft tissue sarcomas are rare and heterogenous malignancies with a poor prognosis in advanced disease stages. Eribulin is used in metastatic liposarcoma (LPS) patients, who have failed first-line chemotherapy...
4.
Gabler J, Basilio J, Steinbrecher O, Kollars M, Kyrle P, Eichinger S
Am J Med Sci
. 2021 Mar;
361(4):509-516.
PMID: 33781391
Background: Venous thromboembolism (VTE) is a frequent and potentially fatal disease, but its pathophysiology is incompletely understood. microRNAs (miR) dysregulate hemostatic proteins and influence thrombotic pathology by posttranscriptional regulation of...
5.
Minichsdorfer C, Steinbrecher O, Kolz M, Schmid M, Raderer M, Brodowicz T, et al.
In Vivo
. 2021 Jan;
35(1):385-391.
PMID: 33402487
Background/aim: Ewing sarcoma (ES) and osteosarcomas (OSA) are the most common bone tumor types in adolescents and young adults (AYA). Therapy management of these tumors consists of preoperative chemotherapy, operation,...
6.
Steinbrecher O, Sinkovec H, Eischer L, Kyrle P, Eichinger S
Thromb Res
. 2020 Nov;
197:160-164.
PMID: 33220565
Introduction: D-dimer measured shortly after discontinuation of anticoagulation by an immunoturbidimetric assay predicts the risk of recurrent venous thromboembolism (VTE). We assessed the performance of this assay over time and...
7.
Traby L, Kollars M, Kaider A, Siller-Matula J, Steinbrecher O, Wolzt M, et al.
Clin Pharmacol Ther
. 2020 Nov;
109(6):1546-1554.
PMID: 33141921
Dual antiplatelet therapy (DAPT) is standard in acute coronary syndrome but confers a bleeding risk. To compare effects of clopidogrel single antiplatelet therapy (SAPT) with clopidogrel-based DAPT on hemostatic system...
8.
Steinbrecher O, Mitrovic M, Eischer L, Sinkovec H, Eichinger S, Kyrle P
Haematologica
. 2020 Jan;
105(4):e198-e201.
PMID: 31974196
No abstract available.
9.
Eichinger S, Eischer L, Sinkovec H, Wittgruber G, Traby L, Kammer M, et al.
PLoS One
. 2018 Mar;
13(3):e0193735.
PMID: 29590126
Background: Patients with spinal cord injury (SCI) are at risk of thrombosis and bleeding. Data on the risks during rehabilitation are inconsistent, and thromboprophylactic strategies are heterogeneous. We aimed to...